CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 84 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,754 | -25.3% | 49,421 | -0.4% | 0.04% | -26.5% |
| Q2 2023 | $85,306 | +113.9% | 49,596 | +87.8% | 0.05% | +133.3% |
| Q1 2023 | $39,884 | +0.6% | 26,412 | +6.6% | 0.02% | 0.0% |
| Q4 2022 | $39,660 | -44.1% | 24,787 | -48.2% | 0.02% | -44.7% |
| Q3 2022 | $71,000 | +6.0% | 47,869 | +33.3% | 0.04% | +18.8% |
| Q2 2022 | $67,000 | +67.5% | 35,919 | +145.3% | 0.03% | +113.3% |
| Q1 2022 | $40,000 | -35.5% | 14,644 | +6.5% | 0.02% | -28.6% |
| Q4 2021 | $62,000 | -8.8% | 13,744 | +2.6% | 0.02% | -16.0% |
| Q3 2021 | $68,000 | – | 13,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |